Residual effects of daytime administration of melatonin on performance relevant to flight.
There is a general consensus that melatonin possesses time-dependent hypnotic effects, but there is no information yet whether it has residual effects on neurobehavioral performance, especially after daytime administration. In the present study we investigated the possible residual effects of 3 mg melatonin on performance relevant to flight and on subjective feelings of sleepiness, arousal, activation and affect after a daytime nap, as a function of nap length. Fifteen reserve pilots of the Israeli Air Force participated in the study. The experiment consisted of four sessions during which either melatonin or placebo was administered at 16:00 h. In two conditions, subjects were allowed to sleep for 2 h (17:00-19:00 h) whereas in the other two only a 0.5-h nap was allowed. After the naps they started performing a flight simulator task every 2 h. Sleep efficiency significantly increased and sleep latency significantly decreased in both melatonin conditions compared to placebo. Flight performance was only mildly affected in the 0.5-h nap condition. Subjective assessment of sleepiness significantly differed between the two treatment conditions, only in the 0.5-h nap condition. Subjects felt sleepier 2-4 h after melatonin administration. To conclude, our data suggest that administration of melatonin before a brief daytime nap (about 0.5 h) may be associated with mild residual effects on psychomotor performance and may significantly affect subjective feeling of sleepiness for 2-4 h.
Nave
Rachel
R
Sleep Research Laboratory, Faculty of Medicine, Technion-Israel Institute of Technology, Gutwirth Building, 32000, Haifa, Israel.
Iani
Cristina
C
Herer
Paula
P
Gopher
Daniel
D
Lavie
Peretz
P
D000328:Adult; D000339:Affect / Q000187:drug effects; D001359:Aviation; D002940:Circadian Rhythm / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D008550:Melatonin / Q000494:pharmacology*; D017286:Polysomnography / Q000187:drug effects; D011597:Psychomotor Performance / Q000187:drug effects*; D012890:Sleep / Q000502:physiology; D012894:Sleep Stages / Q000187:drug effects
D008550:Melatonin